Less than 7% of individuals with mental health or substance use disorders receive effective treatment worldwide, according to a cross-sectional analysis published in JAMA Psychiatry.The findings ...
The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality ...
For more information about mental health care resources and support ... speak out about protecting his legacy and discuss ...
Dr. Jordi Xaus, Oryzon’s CSO, stated, “We are pleased to publish these results in this prestigious clinical psychiatry journal as part of Oryzon’s continuous efforts to expand the current ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback